Article

Glycan microarray profiling of parasite infection sera identifies the LDNF glycan as a potential antigen for serodiagnosis of trichinellosis.

Centre for Infectious Disease Control Netherlands, National Institute of Public Health and Environment, Bilthoven, The Netherlands.
Experimental Parasitology (impact factor: 2.12). 08/2011; 129(3):221-6. DOI:10.1016/j.exppara.2011.08.015 pp.221-6
Source: PubMed

ABSTRACT Diagnostic methods for parasite infections still highly depend on the identification of the parasites by direct methods such as microscopic examination of blood, stool and tissue biopsies. Serodiagnosis is often carried out to complement the direct methods; however, few synthetic antigens with sufficient sensitivity and specificity are available. Here we evaluated a glycan microarray approach to select for synthetic glycan antigens that could be used for serodiagnosis of parasitic infections. Using a glycan array containing over 250 different glycan antigens, we identified GalNAcβ1-4(Fucα1-3)GlcNAc-R (LDNF) as a glycan antigen that is recognized by antibodies from Trichinella-infected individuals. We synthesized a neoglycoconjugate, consisting of five LDNF molecules covalently coupled to bovine serum albumin (BSA), and used this neoglycoconjugate as an antigen to develop a highly sensitive total-Ig ELISA for serological screening of trichinellosis. The results indicate that glycan microarrays constitute a promising technology for fast and specific identification of parasite glycan antigens to improve serodiagnosis of different parasitic infections, either using an ELISA format, or parasite-specific glycan arrays.

0 0
 · 
0 Bookmarks
 · 
53 Views

Keywords

250 different glycan antigens
 
bovine serum albumin
 
Diagnostic methods
 
different parasitic infections
 
direct methods
 
ELISA format
 
glycan antigen
 
glycan array
 
glycan microarray approach
 
glycan microarrays
 
LDNF molecules covalently
 
parasite glycan antigens
 
parasite infections
 
parasite-specific glycan arrays
 
parasitic infections
 
promising technology
 
sensitive total-Ig ELISA
 
serological screening
 
synthetic antigens
 
synthetic glycan antigens